Avidity Biosciences
195 hedge funds and large institutions have $4.57B invested in Avidity Biosciences in 2024 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 74 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
23% more funds holding
Funds holding: 158 → 195 (+37)
5.06% more ownership
Funds ownership: 112.02% → 117.08% (+5.1%)
32% less call options, than puts
Call options by funds: $7.63M | Put options by funds: $11.2M
Holders
195
Holding in Top 10
9
Calls
$7.63M
Puts
$11.2M
Top Buyers
| 1 | +$142M | |
| 2 | +$105M | |
| 3 | +$100M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$98.7M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$86.5M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$20.4M | |
| 3 | -$17.3M | |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
-$17M |
| 5 |
JPMorgan Chase & Co
New York
|
-$16.8M |